Abstract:
Disclosed in this invention are a novel enzyme producing tartaric acid ether compound which catalyzes a reaction of producing a tartaric acid ether compound in which the phenolic hydroxyl group(s) of a flavonoid or its analogous compound having at least one phenolic hydroxyl group is (are) acted to the epoxy ring of an epoxysuccinic acid to form ether linkage of one or more tartaric acid residues, a process for producing a tartaric acid ether compound by acting the enzyme in the presence of an epoxy-succinic acid and a flavonoid or its analogous compound having at least one phenolic hydroxyl group, and novel tartaric acid ether compounds in which the epoxy ring of an epoxysuccinic acid is bound to the phenolic hydroxyl group(s) of a flavonoid or its analogous compound to form ether linkage of one or more tartaric acid residues. These compounds are useful as a component material of pharmaceuticals and functional foods.
Abstract:
PROBLEM TO BE SOLVED: To obtain a new cyclic structure-bearing fluorine-containing monomer that is useful as a raw material for a functional material, a medicine/agrochemical, etc., has excellent transparency to radiation with a wavelength of above all ≤500 nm, especially ≤300 nm and is exceedingly useful as a monomer for producing a base resin of a radiation-sensitive resist composition having improved development properties due to having a phenol-like acidic hydroxy group, to use the polymer of the monomer as a base resin for a radiation-sensitive resist composition and to effectively utilize a hydroxy group having proper acidity so as to reduce, for example, swelling, prevent pattern degradation, suppress T-top shape development and improve dimensional uniformity. SOLUTION: The cyclic structure-bearing fluorine-containing monomer is represented by general formula (1) (Z is a polymerizable unsaturated group-containing bifunctional organic group). COPYRIGHT: (C)2006,JPO&NCIPI
Abstract:
PROBLEM TO BE SOLVED: To provide a new compound having ≥1 μm maximum absorption wavelength, good solubility, and high thermal resistance, and its manufacturing method. SOLUTION: The compound is represented by formula (I) (wherein X 1 to X 10 and Y 1 to Y 10 may be the same or different and each is any one of hydrogen, a straight chain alkyl group, a branched chain alkyl group, an alkoxy group, a cyano group, a nitro group, a halogen, a di-substituted amino group, a substituted or unsubstituted aryl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryloxy group, and a substituted or unsubstituted aralkyloxy group). COPYRIGHT: (C)2005,JPO&NCIPI
Abstract:
PROBLEM TO BE SOLVED: To provide a method for industrially producing a lactone or a carboxylic acid advantageous in economical and operational aspects. SOLUTION: The method for producing the lactone or the carboxylic acid is to react a cyclic ether with hydrogen peroxide in the presence of a metal oxide catalyst which is obtained by reacting at least one species selected from a group comprising metal W, metal Mo, a tungsten compound comprising W and an element of IIIb, IVb, Vb or VIb group and a Mo compound comprising Mo and an element of IIIb, IVb, Vb or VIb group with hydrogen peroxide. COPYRIGHT: (C)2004,JPO
Abstract:
The present invention is directed to new bicyclic compounds of the formula [I],and pharmaceutically acceptable salts thereof wherein R1, R2, R3, R4, R5, R6, R7, Q1 Q2 and Q3 are as defined in the claims. The compounds have N-myristoyltransferase inhibitory and antifungal activity.